Literature DB >> 8094770

High serum procalcitonin concentrations in patients with sepsis and infection.

M Assicot1, D Gendrel, H Carsin, J Raymond, J Guilbaud, C Bohuon.   

Abstract

High concentrations of calcitonin-like immunoreactivity have been found in the blood of patients with various extrathyroid diseases. By means of a monoclonal immunoradiometric assay for calcitonin precursors, we have measured serum concentrations of procalcitonin in patients with various bacterial and viral infections. 79 children (newborn to age 12 years) in hospital with suspected infections were investigated prospectively. 19 patients with severe bacterial infections had very high serum concentrations of procalcitonin at diagnosis (range 6-53 ng/mL) in comparison with 21 children found to have no signs of infection (baseline concentrations < 0.1 ng/mL). Serum procalcitonin values decreased rapidly during antibiotic therapy. 11 patients with peripheral bacterial colonisation or local infections without invasive sepsis and 18 (86%) of 21 patients with viral infections had concentrations within or slightly above the normal range (0.1-1.5 ng/mL). Among 9 severely burned patients studied in an intensive care unit, the post-traumatic course of procalcitonin concentrations (range 0.1-120 ng/mL) was closely related to infectious complications and acute septic episodes. Concentrations of mature calcitonin were normal in all subjects, whatever procalcitonin concentrations were found. Concentrations of a substance immunologically identical to procalcitonin are raised during septic conditions. Serum concentrations seem to be correlated with the severity of microbial invasion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094770      PMCID: PMC7141580          DOI: 10.1016/0140-6736(93)90277-n

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

1.  Letter: Hypersecretion of calcitonin in neoplastic conditions.

Authors:  G Milhaud; C Calmette; J Taboulet; A Julienne; M S Moukhtar
Journal:  Lancet       Date:  1974-03-16       Impact factor: 79.321

2.  Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours.

Authors:  R C Coombes; C Hillyard; P B Greenberg; I MacIntyre
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

3.  Medullary thyroid carcinomas secrete a noncalcitonin peptide corresponding to the carboxyl-terminal region of preprocalcitonin.

Authors:  B A Roos; M B Huber; R S Birnbaum; D C Aron; A W Lindall; K Lips; S B Baylin
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

4.  Immunoreactive parathyroid hormone and calcitonin in plasma and ultrafiltrate before and after haemodialysis.

Authors:  P Fauchald; V T Gautvik; K M Gautvik
Journal:  Scand J Clin Lab Invest       Date:  1985-05       Impact factor: 1.713

5.  Calcitonin gene-related peptide levels are elevated in patients with sepsis.

Authors:  C D Joyce; R R Fiscus; X Wang; D J Dries; R C Morris; R A Prinz
Journal:  Surgery       Date:  1990-12       Impact factor: 3.982

6.  Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.

Authors:  P P Ghillani; P Motté; F Troalen; A Jullienne; P Gardet; T Le Chevalier; P Rougier; M Schlumberger; C Bohuon; D Bellet
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

7.  A novel calcitonin carboxyl-terminal peptide produced in medullary thyroid carcinoma by alternative RNA processing of the calcitonin/calcitonin gene-related peptide gene.

Authors:  S Minvielle; S Giscard-Dartevelle; R Cohen; J Taboulet; F Labye; A Jullienne; P Rivaille; G Milhaud; M S Moukhtar; F Lasmoles
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

8.  Immunocytochemical localization of calcitonin in Kulchitsky cells of human lung.

Authors:  K L Becker; K G Monaghan; O L Silva
Journal:  Arch Pathol Lab Med       Date:  1980-04       Impact factor: 5.534

9.  Calcitonin levels in chronic renal disease.

Authors:  O L Silva; K L Becker; R J Shalhoub; R H Snider; L E Bivins; C F Moore
Journal:  Nephron       Date:  1977       Impact factor: 2.847

10.  Increased serum and urinary calcitonin levels in patients with pulmonary disease.

Authors:  K L Becker; D Nash; O L Silva; R H Snider; C F Moore
Journal:  Chest       Date:  1981-02       Impact factor: 9.410

View more
  428 in total

1.  Procalcitonin is not produced by circulating blood cells.

Authors:  G Monneret; B Laroche; J Bienvenu
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Biomarkers of sepsis: is procalcitonin ready for prime time?

Authors:  Jérôme Pugin
Journal:  Intensive Care Med       Date:  2002-09       Impact factor: 17.440

3.  Expression and localization of prohormone convertase PC1 in the calcitonin-producing cells of the bullfrog ultimobranchial gland.

Authors:  Yuichi Yaoi; Masakazu Suzuki; Hideaki Tomura; Shingo Kurabuchi; Yuichi Sasayama; Shigeyasu Tanaka
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

4.  Use of quantitative and semiquantitative procalcitonin measurements to identify children with sepsis and meningitis.

Authors:  C Prat; J Domínguez; C Rodrigo; M Giménez; M Azuara; S Blanco; V Ausina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-19       Impact factor: 3.267

Review 5.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

Review 6.  Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections.

Authors:  Hui Li; Yi-Feng Luo; Timothy S Blackwell; Can-Mao Xie
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

Review 7.  Use of plasma procalcitonin levels as an adjunct to clinical microbiology.

Authors:  David N Gilbert
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

8.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage.

Authors:  Emir Festic; Jason Siegel; Matthew Stritt; William D Freeman
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

10.  Postoperative plasma concentrations of procalcitonin after different types of surgery.

Authors:  M Meisner; K Tschaikowsky; A Hutzler; C Schick; J Schüttler
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.